Novel transcript, antisense to ATRNL1

ENSG00000285582 represents a **long non-coding antisense RNA transcript** located on the opposite strand of the ATRNL1 gene locus. Antisense transcripts like this one do not encode proteins, but instead function primarily as regulatory RNAs that can modulate the expression of their sense (protein-coding) gene partner (in this case, ATRNL1) through a variety of mechanisms including transcriptional interference, recruitment of epigenetic modifiers, and RNA duplex formation affecting splicing or stability[2][5]. There is currently no evidence supporting a direct therapeutic or biomarker role, nor is it classified as a drug target or disease marker[1]. Its primary relevance is potential regulation of ATRNL1 expression, which itself has documented roles in cardiac and neurological functions[3][4]. No interacting drugs, safety concerns, or direct clinical implications are known for this transcript.